Altoida is starting a five-year study to feed its app-based Precision Neurology device with data from thousands of patients across all stages of Alzheimer’s, to help validate the device’s ability to diagnose the disease at the earliest phases. The device will use artificial intelligence (AI) to collect and analyze the results of a series of augmented reality and motor activities that simulate real-world activities of daily living. These activities can be completed on a smartphone…
You must be logged in to read/download the full post.
The post Altoida Starts Five-year Study to Validate Disease-predicting App appeared first on BioNewsFeeds.